Financial Management Professionals’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.06K | Sell |
155
-93
| -38% | -$3.64K | ﹤0.01% | 607 |
|
2025
Q1 | $9.61K | Buy |
248
+51
| +26% | +$1.98K | ﹤0.01% | 532 |
|
2024
Q4 | $6.66K | Buy |
197
+176
| +838% | +$5.95K | ﹤0.01% | 574 |
|
2024
Q3 | $1K | Sell |
21
-3
| -13% | -$143 | ﹤0.01% | 834 |
|
2024
Q2 | $1K | Buy |
24
+8
| +50% | +$333 | ﹤0.01% | 789 |
|
2024
Q1 | $1K | Sell |
16
-134
| -89% | -$8.38K | ﹤0.01% | 853 |
|
2023
Q4 | $6K | Buy |
+150
| New | +$6K | ﹤0.01% | 631 |
|
2023
Q2 | – | Sell |
-127
| Closed | -$5K | – | 995 |
|
2023
Q1 | $5K | Buy |
127
+43
| +51% | +$1.69K | ﹤0.01% | 681 |
|
2022
Q4 | $3K | Sell |
84
-10
| -11% | -$357 | ﹤0.01% | 686 |
|
2022
Q3 | $3K | Sell |
94
-52
| -36% | -$1.66K | ﹤0.01% | 676 |
|
2022
Q2 | $8K | Buy |
146
+28
| +24% | +$1.53K | ﹤0.01% | 535 |
|
2022
Q1 | $6K | Buy |
118
+39
| +49% | +$1.98K | ﹤0.01% | 603 |
|
2021
Q4 | $4K | Hold |
79
| – | – | ﹤0.01% | 611 |
|
2021
Q3 | $4K | Hold |
79
| – | – | ﹤0.01% | 615 |
|
2021
Q2 | $4K | Sell |
79
-44
| -36% | -$2.23K | ﹤0.01% | 557 |
|
2021
Q1 | $5K | Sell |
123
-1,275
| -91% | -$51.8K | ﹤0.01% | 475 |
|
2020
Q4 | $64K | Buy |
1,398
+60
| +4% | +$2.75K | 0.02% | 191 |
|
2020
Q3 | $63K | Sell |
1,338
-303
| -18% | -$14.3K | 0.02% | 169 |
|
2020
Q2 | $84K | Buy |
1,641
+1,294
| +373% | +$66.2K | 0.03% | 122 |
|
2020
Q1 | $16K | Hold |
347
| – | – | 0.01% | 147 |
|
2019
Q4 | $20K | Buy |
347
+3
| +0.9% | +$173 | 0.01% | 146 |
|
2019
Q3 | $18K | Buy |
+344
| New | +$18K | 0.01% | 147 |
|
2016
Q3 | – | Sell |
-265
| Closed | -$14K | – | 347 |
|
2016
Q2 | $14K | Buy |
+265
| New | +$14K | 0.01% | 172 |
|